Back to search

Article

HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma

2022-12-21

Abstract excerpt

<title>Abstract</title> <p>Objective Uterine carcinosarcoma (UCS) is uncommon high-grade endometrial cancer with limited treatment options. We evaluated prognostic significance of HER2 expression and <italic>HER2</italic> gene amplification within large cohorts of UCS, and clarify clinicopathologic characteristics of HER2-low UCS. Methods We examined HER2 protein expression in 148 patients of UCS using IVD HER2...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4621da65-f290-5473-9013-582cebb159e4
DOI
10.21203/rs.3.rs-2369378/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcomaDOI 10.21203/rs.3.rs-2369378/v1
β-catenin is a potential prognostic biomarker in uterine sarcomaSemantic proximity
Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype?Semantic proximity
HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteriaSemantic proximity
An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification.Semantic proximity
HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese populationSemantic proximity
HER2 Evaluation in Uterine Serous Carcinoma: Diagnostic Agreement Between Biopsy and Resection SamplesSemantic proximity
Clinical Significance and Genetic Characteristics in HER2 Low Expression Tumors of Hormone Receptor Positive Breast Cancer PatientsSemantic proximity
High-grade Endometrial Stromal Sarcoma With BCOR Gene Alterations is Recommended as an Independent Subtype of Endometrial Carcinoma: A Case ReportSemantic proximity
Exploring the Heterogeneity of HER2 gene status and Expression in Non-Positive Breast Cancer Patients: Insights from Immunohistochemistry and Fluorescence In Situ HybridizationSemantic proximity
High expression of S100A2 predicts poor prognosis in patients with endometrial carcinomaSemantic proximity
<i>HER2</i>Amplification in Gastroesophageal AdenocarcinomaSemantic proximity
Characteristics of HER2 Gene Amplification by Fluorescence In Situ Hybridization in Endometrial Serous Carcinoma: Implications for Clinical HER2 Testing and InterpretationSemantic proximity
Select a neighboring publication to make it the new centre.